First Report of DHA-1 Producing Enterobacter cloacae Complex Isolate in Bulgaria

Autor: Dobromira I. Dimitrova, Rumyana D. Markovska, Temenuga J. Stoeva, Petya B. Stankova, Lyudmila B. Georgieva, Kalina I. Mihova, Radka P. Kaneva, Ivan G. Mitov
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Folia Medica, Vol 61, Iss 3, Pp 458-461 (2019)
Druh dokumentu: article
ISSN: 1314-2143
0204-8043
DOI: 10.3897/folmed.61.e39349
Popis: The aim of the present study was to reveal the characteristics of an Enterobacter cloacae complex isolate producing DHA-1 AmpC enzyme recovered from a patient hospitalized in St Marina Hospital, Varna.Materials and methods: Susceptibility testing, conjugation experiments, isoelectric focusing, PCR and sequencing were carrying out.Results: Of 176 Enterobacter spp. isolates only one isolate was positive for blaDHA. The sequencing revealed the presence of blaDHA-1 and blaCTX-M-3. The antimicrobial susceptibility testing showed higher resistance rates to almost all beta-lactams (ceftazidime, cefotaxime, cefepime, amoxicillinclavulanic acid, piperacillin/tazobactam), tobramycin, gentamycin, trimethoprim/sulphomethoxazole and quinolones (ciprofloxacin and levofloxacin). The isolate was susceptible to imipenem, meropenem and amikacin. The isoelectric focusing showed a band at pI 5.4 without ceftazidime and cefotaxime activity; a band at pI 7.8 with cefoxitin activity and another - with pI 8.4 with cefotaxime activity. Conjugation experiments were successful only for blaCTX-M-3 carrying determinants. Conclusions: To the best of our knowledge this is the first report of DHA-1 producing isolate in Bulgaria. The emergence of DHA-1 producing E. cloacae complex demonstrates the possibility for further dissemination of the gene encoding this enzyme. Infectious control measures are needed for the prevention of this phenomenon.
Databáze: Directory of Open Access Journals